PD-L1 IHC maintains suboptimal accuracy and reproducibility and offers limited information about the tumor microenvironment (TME).6–8 High tumor mutational burden (TMB) has also been correlated with response to ICI. This evidence concerns the gene CD274 and neoplasm.